UK markets open in 5 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,189.55 +426.52 (+2.40%) CRUDE OIL
79.48 +0.48 (+0.61%) GOLD FUTURES
2,323.00 +12.00 (+0.52%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,966.58 -1,643.05 (-3.45%)
Wilmar International Limited (F34.SI)
SES - SES Delayed price. Currency in SGD
Add to watchlist
As of 02:43PM SGT. Market open.
| Previous close | 3.2300 |
| Open | 3.2000 |
| Bid | 3.2000 x 0 |
| Ask | 3.2100 x 0 |
| Day's range | 3.2000 - 3.2400 |
| 52-week range | 3.0700 - 4.1000 |
| Volume | |
| Avg. volume | 5,506,604 |
| Market cap | 19.977B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.70 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.17 (5.26%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.